Clinical features of pseudocirrhosis in metastatic breast cancer.
Caspian OliaiMichael L DouekCaelainn RhoaneAbhishek BhutadaPhillip S GeBruce A RunyonXiaoyan WangSara Alsterlind HurvitzPublished in: Breast cancer research and treatment (2019)
Pseudocirrhosis does not occur in the absence of liver metastases, can manifest as hepatic decompensation, and appears to be associated with poorer survival amongst patients with hepatic metastases. Higher cumulative exposure to systemic therapy may be causative, instead of the previously held belief of pseudocirrhosis as an adverse effect of a particular systemic agent/class.